reboxetine has been researched along with Alcoholism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alen, F; Arco, R; Ballesta, A; Decara, J; Gómez de Heras, R; Orio, L; Pavón, FJ; Ramírez-López, M; Rodríguez de Fonseca, F; Serrano, A; Suárez, J; Vadas, E; Vargas, A | 1 |
| Camarasa, X; Duboc, A; Khazaal, Y; Lopez-Martinez, E; Zullino, DF | 1 |
1 trial(s) available for reboxetine and Alcoholism
| Article | Year |
|---|---|
Escitalopram/reboxetine combination in depressed patients with substance use disorder.
Topics: Adult; Alcoholism; Antidepressive Agents; Bipolar Disorder; Citalopram; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Combinations; Female; Humans; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Substance-Related Disorders | 2005 |
1 other study(ies) available for reboxetine and Alcoholism
| Article | Year |
|---|---|
Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking.
Topics: Alcoholism; Animals; Drug-Seeking Behavior; Endocannabinoids; Glutamic Acid; Hippocampus; Male; Prefrontal Cortex; Rats; Rats, Wistar; Reboxetine; Self Administration; Signal Transduction; Substance Withdrawal Syndrome | 2021 |